Meeder Asset Management Inc Eli Lilly & CO Transaction History

Meeder Asset Management Inc

  • $1.48 Billion
  • Q3 2024

A detailed history of Meeder Asset Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Meeder Asset Management Inc holds 37,587 shares of LLY stock, worth $29.9 Million. This represents 2.25% of its overall portfolio holdings.

Number of Shares
37,587
Previous 32,420 15.94%
Holding current value
$29.9 Million
Previous $29.4 Million 13.45%
% of portfolio
2.25%
Previous 2.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$772.14 - $960.02 $3.99 Million - $4.96 Million
5,167 Added 15.94%
37,587 $33.3 Million
Q2 2024

Aug 08, 2024
BUY
$724.87 - $909.04 $6.06 Million - $7.6 Million
8,355 Added 34.72%
32,420 $29.4 Million
Q1 2024

May 07, 2024
BUY
$592.2 - $792.28 $8.83 Million - $11.8 Million
14,909 Added 162.83%
24,065 $18.7 Million
Q4 2023

Jan 25, 2024
SELL
$525.19 - $619.13 $8.47 Million - $9.99 Million
-16,135 Reduced 63.8%
9,156 $5.34 Million
Q3 2023

Nov 13, 2023
SELL
$434.7 - $599.3 $1.65 Million - $2.27 Million
-3,789 Reduced 13.03%
25,291 $13.6 Million
Q2 2023

Aug 11, 2023
BUY
$350.74 - $468.98 $5.35 Million - $7.16 Million
15,265 Added 110.5%
29,080 $13.6 Million
Q1 2023

May 15, 2023
SELL
$310.63 - $364.82 $5.03 Million - $5.91 Million
-16,191 Reduced 53.96%
13,815 $4.74 Million
Q4 2022

Feb 14, 2023
SELL
$321.55 - $374.67 $2.84 Million - $3.31 Million
-8,833 Reduced 22.74%
30,006 $11 Million
Q3 2022

Nov 14, 2022
BUY
$296.48 - $337.87 $10,969 - $12,501
37 Added 0.1%
38,839 $12.6 Million
Q2 2022

Aug 08, 2022
BUY
$278.73 - $327.27 $1.12 Million - $1.31 Million
4,010 Added 11.53%
38,802 $12.6 Million
Q1 2022

May 10, 2022
BUY
$234.69 - $291.66 $2.2 Million - $2.74 Million
9,390 Added 36.97%
34,792 $9.96 Million
Q4 2021

Feb 11, 2022
SELL
$224.85 - $279.04 $2.13 Million - $2.65 Million
-9,494 Reduced 27.21%
25,402 $7.02 Million
Q3 2021

Nov 08, 2021
SELL
$221.6 - $272.71 $360,764 - $443,971
-1,628 Reduced 4.46%
34,896 $8.06 Million
Q2 2021

Aug 09, 2021
SELL
$180.55 - $233.54 $43,332 - $56,049
-240 Reduced 0.65%
36,524 $8.38 Million
Q1 2021

Apr 28, 2021
BUY
$164.32 - $212.72 $5.34 Million - $6.92 Million
32,524 Added 767.08%
36,764 $6.87 Million
Q4 2020

Feb 09, 2021
SELL
$130.46 - $172.63 $5.73 Million - $7.59 Million
-43,959 Reduced 91.2%
4,240 $716,000
Q3 2020

Nov 02, 2020
SELL
$146.22 - $169.13 $1.8 Million - $2.08 Million
-12,299 Reduced 20.33%
48,199 $7.13 Million
Q2 2020

Aug 11, 2020
SELL
$136.42 - $164.18 $811,971 - $977,199
-5,952 Reduced 8.96%
60,498 $9.93 Million
Q1 2020

May 15, 2020
SELL
$119.05 - $147.35 $1.42 Million - $1.76 Million
-11,916 Reduced 15.21%
66,450 $9.22 Million
Q4 2019

Feb 13, 2020
BUY
$106.92 - $132.43 $408,969 - $506,544
3,825 Added 5.13%
78,366 $10.3 Million
Q3 2019

Oct 17, 2019
BUY
$106.79 - $116.16 $18,261 - $19,863
171 Added 0.23%
74,541 $8.34 Million
Q2 2019

Aug 05, 2019
BUY
$110.79 - $129.32 $2.54 Million - $2.96 Million
22,887 Added 44.46%
74,370 $8.24 Million
Q1 2019

Apr 16, 2019
BUY
$111.31 - $131.02 $570,797 - $671,870
5,128 Added 11.06%
51,483 $6.68 Million
Q4 2018

Jan 17, 2019
BUY
$105.9 - $118.64 $2.4 Million - $2.68 Million
22,631 Added 95.39%
46,355 $5.36 Million
Q3 2018

Nov 02, 2018
BUY
$85.86 - $107.31 $1.33 Million - $1.66 Million
15,442 Added 186.45%
23,724 $0
Q2 2018

Jul 24, 2018
BUY
$75.7 - $86.88 $373,276 - $428,405
4,931 Added 147.15%
8,282 $0
Q1 2018

May 03, 2018
BUY
$74.21 - $87.6 $45,342 - $53,523
611 Added 22.3%
3,351 $259,000
Q4 2017

Feb 02, 2018
BUY
$81.94 - $87.89 $55,719 - $59,765
680 Added 33.01%
2,740 $231,000
Q3 2017

Oct 20, 2017
BUY
$77.07 - $85.54 $158,764 - $176,212
2,060
2,060 $176,000

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email